News

Amgen is closing on a deal to acquire Onyx Pharmaceuticals after getting access to data on a key cancer drug , although reports suggest it is reining in the price it is prepared to pay.

The global market for drugs to treat dyslipidemia will grow by an average of around 2% a year from 2012 to 2022, by which time it will be worth just over $31 billion, according to new research.

Eli Lilly has become the latest pharma company to be accused in the Chinese press of bribery and corruption.

Takeda is expanding further into the emerging market of Latin America after launching a sales and marketing headquarters in Lima, Peru.

The UK Competition Commission (CC) is inviting evidence on whether to remove undertakings which restrict the way IMS Health sells its specialised pharmaceutical data services.

Seventy percent more men in the UK are dying from malignant melanoma, the deadliest form of skin cancer, than women.

The UK government has called health ministers from the G8 nations to the first ever global summit on dementia to help improve management of the disease and accelerate the development of new treatments.

The US-based Alliance for Clinical Research Excellence and Safety (ACRES) is rolling out an online interface for clinical-research sites worldwide in collaboration with two of its technology partners, ViS Research and HealthCarePoint (HCP).

Shares in Incyte were trading up nearly 34% yesterday after posting promising mid-stage data for its pancreatic cancer therapy.

Clinical research organisations (CROs) continue to struggle with talent retention as employee turnover rates remain around the 20% mark, preliminary results of a survey by US-based compensation consulting and research firm HR+Survey Solutions indicate.

A new project launched by UK-based charity The Olusegun Obasanjo Foundation aims to divert surplus medical supplies from clinical trials free of charge to teaching hospitals and clinical practices in Africa.   

The global shift towards making research findings available free of charge for readers is reaching the tipping point, with around 50% of scientific papers published in 2011 now available for free, according to a new study conducted for the European Commission. 

A husband and wife corporate investigation team that have reportedly worked for GlaxoSmithKline have been arrested in China.

Bayer chalked up another approval for blockbuster-in-waiting Stivarga after Japan gave a green light for the drug’s use in gastrointestinal stromal tumour (GIST).

US regulators have granted Novartis’ experimental muscle wasting drug ‘breakthrough’ status, potentially giving it a fast-track to approval.